Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase ExpressionFanny Chalmin, François Ghiringhelli, Grégoire Mignot et al.|Immunity|2012Cited by 324
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?Lionel Apétoh, François Ghiringhelli|Annals of Oncology|2015Cited by 284
CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T<sub>H</sub>1 and T<sub>H</sub>9 cellsIsis Benoit-Lizon, Lionel Apétoh, Stéphane Giorgiutti et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 80
SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer GrowthHélène Berger, Lionel Apétoh|Cancer Research|2013Cited by 52
Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint InhibitorsMagalie Dosset, Lionel Apétoh|Cells|2020Cited by 11